ITRM940625A0 - "uso di esteri ftalidilidenici della carnitina e di alcanoil carnitineper il trattamento dello shock endotossico" - Google Patents

"uso di esteri ftalidilidenici della carnitina e di alcanoil carnitineper il trattamento dello shock endotossico"

Info

Publication number
ITRM940625A0
ITRM940625A0 ITRM940625A ITRM940625A ITRM940625A0 IT RM940625 A0 ITRM940625 A0 IT RM940625A0 IT RM940625 A ITRM940625 A IT RM940625A IT RM940625 A ITRM940625 A IT RM940625A IT RM940625 A0 ITRM940625 A0 IT RM940625A0
Authority
IT
Italy
Prior art keywords
carnitine
phthaldylydenese
esters
treatment
alkanoyl
Prior art date
Application number
ITRM940625A
Other languages
English (en)
Inventor
Vito Ruggiero
Piero Foresta
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to ITRM940625A priority Critical patent/IT1273987B/it
Publication of ITRM940625A0 publication Critical patent/ITRM940625A0/it
Priority to EP95830373A priority patent/EP0706793A3/en
Priority to US08/530,581 priority patent/US5814661A/en
Priority to JP7250853A priority patent/JPH08183734A/ja
Publication of ITRM940625A1 publication Critical patent/ITRM940625A1/it
Application granted granted Critical
Publication of IT1273987B publication Critical patent/IT1273987B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
ITRM940625A 1994-09-29 1994-09-29 Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico IT1273987B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITRM940625A IT1273987B (it) 1994-09-29 1994-09-29 Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico
EP95830373A EP0706793A3 (en) 1994-09-29 1995-09-08 Use of phthalidylidene esters of carnitine and alkanoyl carnitides for the treatment of endotoxic shock
US08/530,581 US5814661A (en) 1994-09-29 1995-09-19 Use of Phthalidyliden esters of carnitine and alkanoyl carnitines for the treatment of endotoxic shock
JP7250853A JPH08183734A (ja) 1994-09-29 1995-09-28 内毒素ショックの処置へのカルニチンおよびアルカノイルカルニチン類のフタリジリデンエステル類の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940625A IT1273987B (it) 1994-09-29 1994-09-29 Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico

Publications (3)

Publication Number Publication Date
ITRM940625A0 true ITRM940625A0 (it) 1994-09-29
ITRM940625A1 ITRM940625A1 (it) 1996-03-29
IT1273987B IT1273987B (it) 1997-07-14

Family

ID=11402748

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940625A IT1273987B (it) 1994-09-29 1994-09-29 Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico

Country Status (4)

Country Link
US (1) US5814661A (it)
EP (1) EP0706793A3 (it)
JP (1) JPH08183734A (it)
IT (1) IT1273987B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
US10330685B2 (en) 2014-05-01 2019-06-25 The Regents Of The University Of Michigan Markers for sepsis treatment
US12478603B2 (en) 2020-03-31 2025-11-25 The Regents Of The University Of Michigan Serum metabolites as biomarkers for carnitine treatment of sepsis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045518A (ja) * 1983-08-22 1985-03-12 Takeda Chem Ind Ltd 抗シヨツク剤
IT1242020B (it) 1990-11-20 1994-02-02 Sigma Tau Ind Farmaceuti Ftalidilidene derivati della carnitina e di alcanoil carnitine e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
EP0706793A2 (en) 1996-04-17
US5814661A (en) 1998-09-29
IT1273987B (it) 1997-07-14
JPH08183734A (ja) 1996-07-16
EP0706793A3 (en) 1996-06-26
ITRM940625A1 (it) 1996-03-29

Similar Documents

Publication Publication Date Title
ITMI911228A1 (it) Particelle di carica rivestite e procedimento per preparale
ITMI922242A0 (it) Procedimento per la preparazione di un catalizzatore efficace nella idroisomerizzazione di normal-paraffine
ID18679A (id) Penggunaan terapi lanjutan
BR9502691A (pt) Uso de ácido hialurônico e dispositivo protético
FI955182L (fi) Korirakenne
IT1282692B1 (it) Citochine modificate per l'uso in terapia
FI964186L (fi) Ei-liittävät gp350/220-variantit
ITTO950584A0 (it) Struttura di scocca per motorscooter
ITPD920145A0 (it) Uso terapeutico della fosforil-serina-n-acil-sfingosina
ITRM940625A0 (it) "uso di esteri ftalidilidenici della carnitina e di alcanoil carnitineper il trattamento dello shock endotossico"
ZA951521B (en) The use of benzazoles as uv absorbers new benzazoles and a process for their preparation
ITRM960052A0 (it) Peptidi e loro usi nella terapia della malattia celiaca
ITMI911920A1 (it) Apparecchio per il riempimento con paste cosmetiche e metodo di riempimento con l'uso dello stesso apparecchio.
ITRM940072A0 (it) Uso della ribonucleasi seminali per la terapia antimetastatica
KR960023568U (ko) 볼 조인트의 구조와 형상
TW339588U (en) Improved structure of an eyebrow delineator
ITMI931800A0 (it) Uso della 4 -desossi-4-iododoxorubicina per il trattamento della alamiloidosi
KR950016730U (ko) 쑥뜸기의 쑥봉 지지구조
KR960019867U (ko) 의자의 개량구조
ITMI940621A0 (it) Uso della 4'-desossi-4'-idodoxorubicina per il trattamento della al amiloidosi nella malattia di alzheimer
ITMI940068A0 (it) Procedimento per la preparazione di condroitin solfato
KR950031846U (ko) 반두용 지지대의 구조
KR960004350U (ko) 칠판의 받침대 구조
ITMI920725U1 (it) Struttura di affilatore manuale particolarmente per lame e simili
KR960000885U (ko) 쇽 업소버의 바디구조

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970709